Fed. Circ. Bats Down Helsinn Bid To Stay On-Sale Bar Ruling

By Bonnie Eslinger ( January 22, 2018, 10:53 PM EST) -- The Federal Circuit on Monday rejected Helsinn Healthcare's request to stay its ruling invalidating four patents related to an anti-nausea drug while the company seeks to put its case before the U. S. Supreme Court, saying the decision was narrowly tailored and Helsinn didn't show it faces irreparable injury. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Law360 is pleased to announce the Rising Stars of 2025, our list of more than 150 attorneys under 40 whose legal accomplishments belie their age.